Evidence map›Paper›PMID 22610379›Full record

ArticleThe Journal of biological chemistry2012

Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.

Boubacar Benziane, Marie Björnholm, Sergej Pirkmajer, Reginald L Austin, Olga Kotova, Benoit Viollet, Juleen R Zierath, Alexander V Chibalin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. The Venom ofVeterinary sciences · 2024
    Article
  3. Article
  4. Article
  5. Phosphorylation of NaThe Journal of membrane biology · 2021
    Article
  6. Article
  7. Article
  8. The role of AMPK in regulation of NaJournal of muscle research and cell motility · 2021
    Review
  9. Anti-NaScience advances · 2021
    Article
  10. MetforminFrontiers in physiology · 2021
    Article
  11. Article
  12. Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease.International journal of molecular sciences · 2020
    Review
  13. Article
  14. AMPK alleviates high uric acid-induced NaExperimental & molecular medicine · 2019
    Article
  15. Review
  16. Stimulation of NaOxidative medicine and cellular longevity · 2019
    Article
  17. Review
  18. AMP-Activated Protein Kinase (AMPK)-Dependent Regulation of Renal Transport.International journal of molecular sciences · 2018
    Review
  19. DR region of NaScientific reports · 2018
    Article
  20. Regulation of hepatic NaMolecular and cellular biochemistry · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Boubacar BenzianeDepartment of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Marie Björnholm
Sergej Pirkmajer
Reginald L Austin
Olga Kotova
Benoit Viollet
Juleen R Zierath
Alexander V Chibalin
Karolinska Institutet · SEInstitut Cochin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contraction stimulates Na(+),K(+)-ATPase and AMP-activated protein kinase (AMPK) activity in skeletal muscle. Whether AMPK activation affects Na(+),K(+)-ATPase activity in skeletal muscle remains to be determined. Short term stimulation of rat L6 myotubes with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR), activates AMPK and promotes translocation of the Na(+),K(+)-ATPase α(1)-subunit to the plasma membrane and increases Na(+),K(+)-ATPase activity as assessed by ouabain-sensitive (86)Rb(+) uptake. Cyanide-induced artificial anoxia, as well as a direct AMPK activator (A-769662) also increase AMPK phosphorylation and Na(+),K(+)-ATPase activity. Thus, different stimuli that target AMPK concomitantly increase Na(+),K(+)-ATPase activity. The effect of AICAR on Na(+),K(+)-ATPase in L6 myotubes was attenuated by Compound C, an AMPK inhibitor, as well as siRNA-mediated AMPK silencing. The effects of AICAR on Na(+),K(+)-ATPase were completely abolished in cultured primary mouse muscle cells lacking AMPK α-subunits. AMPK stimulation leads to Na(+),K(+)-ATPase α(1)-subunit dephosphorylation at Ser(18), which may prevent endocytosis of the sodium pump. AICAR stimulation leads to methylation and dephosphorylation of the catalytic subunit of the protein phosphatase (PP) 2A in L6 myotubes. Moreover, AICAR-triggered dephosphorylation of the Na(+),K(+)-ATPase was prevented in L6 myotubes deficient in PP2A-specific protein phosphatase methylesterase-1 (PME-1), indicating a role for the PP2A·PME-1 complex in AMPK-mediated regulation of Na(+),K(+)-ATPase. Thus contrary to the common paradigm, we report AMPK-dependent activation of an energy-consuming ion pumping process. This activation may be a potential mechanism by which exercise and metabolic stress activate the sodium pump in skeletal muscle.

Indexed as

Aminoimidazole CarboxamideAMP-Activated Protein KinasesAnimalsBiphenyl CompoundsBlotting, WesternCarboxylic Ester HydrolasesCell HypoxiaCells, CulturedEnzyme ActivationMethylationMiceMice, KnockoutMuscle Fibers, SkeletalMuscle, SkeletalPhosphorylationProtein Kinase C4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrileAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesAtp1a1 protein, ratBiphenyl CompoundsCarboxylic Ester HydrolasesProtein Kinase CProtein Kinase C zetaprotein phosphatase methylesterase-1Protein SubunitsPyronesRibonucleotidesSodium-Potassium-Exchanging ATPaseThiophenes

Identifiers

PMID22610379
PMCPMC3390622
OpenAlexW2097133388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.